{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:29:49Z","timestamp":1778549389483,"version":"3.51.4"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10555-020-09874-x","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T07:02:17Z","timestamp":1588316537000},"page":"415-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Caveola-forming proteins and prostate cancer"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-2697","authenticated-orcid":false,"given":"Zeyad D.","family":"Nassar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-7381","authenticated-orcid":false,"given":"Marie-Odile","family":"Parat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"issue":"6","key":"9874_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"9874_CR2","first-page":"1424","volume":"24","author":"G Palade","year":"1953","unstructured":"Palade, G. (1953). The fine structure of blood capillaries. Journal of Applied Physics, 24, 1424.","journal-title":"Journal of Applied Physics"},{"issue":"50","key":"9874_CR3","doi-asserted-by":"publisher","first-page":"14170","DOI":"10.1073\/pnas.1617954113","volume":"113","author":"RG Parton","year":"2016","unstructured":"Parton, R. G., & Collins, B. M. (2016). Unraveling the architecture of caveolae. Proceedings of the National Academy of Sciences of the United States of America, 113(50), 14170\u201314172. https:\/\/doi.org\/10.1073\/pnas.1617954113.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9874_CR4","doi-asserted-by":"publisher","unstructured":"Parton, R. G., del Pozo, M. A., Vassilopoulos, S., Nabi, I. R., Le Lay, S., Lundmark, R., et al. (2020). Caveolae: the FAQs. Traffic, 21, 181-185. https:\/\/doi.org\/10.1111\/tra.12689.","DOI":"10.1111\/tra.12689"},{"issue":"1","key":"9874_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev-cellbio-100617-062737","volume":"34","author":"RG Parton","year":"2018","unstructured":"Parton, R. G. (2018). Caveolae: structure, function, and relationship to disease. Annual Review of Cell and Developmental Biology, 34(1), 111\u2013136. https:\/\/doi.org\/10.1146\/annurev-cellbio-100617-062737.","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"9874_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/bs.ircmb.2015.07.009","volume":"320","author":"ZD Nassar","year":"2015","unstructured":"Nassar, Z. D., & Parat, M. O. (2015). Cavin family: new players in the biology of caveolae. International Review of Cell and Molecular Biology, 320, 235\u2013305. https:\/\/doi.org\/10.1016\/bs.ircmb.2015.07.009.","journal-title":"International Review of Cell and Molecular Biology"},{"issue":"1","key":"9874_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cell.2007.11.042","volume":"132","author":"MM Hill","year":"2008","unstructured":"Hill, M. M., Bastiani, M., Luetterforst, R., Kirkham, M., Kirkham, A., Nixon, S. J., et al. (2008). PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell, 132(1), 113\u2013124. https:\/\/doi.org\/10.1016\/j.cell.2007.11.042.","journal-title":"Cell"},{"issue":"4","key":"9874_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.cmet.2008.07.008","volume":"8","author":"L Liu","year":"2008","unstructured":"Liu, L., Brown, D., McKee, M., Lebrasseur, N. K., Yang, D., Albrecht, K. H., et al. (2008). Deletion of Cavin\/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metabolism, 8(4), 310\u2013317. https:\/\/doi.org\/10.1016\/j.cmet.2008.07.008.","journal-title":"Cell Metabolism"},{"issue":"5539","key":"9874_CR9","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1126\/science.1062688","volume":"293","author":"M Drab","year":"2001","unstructured":"Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., et al. (2001). Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science, 293(5539), 2449\u20132452. https:\/\/doi.org\/10.1126\/science.1062688.","journal-title":"Science"},{"issue":"1","key":"9874_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0002-9440(10)64370-2","volume":"160","author":"C Minetti","year":"2002","unstructured":"Minetti, C., Bado, M., Broda, P., Sotgia, F., Bruno, C., Galbiati, F., et al. (2002). Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. The American Journal of Pathology, 160(1), 265\u2013270. https:\/\/doi.org\/10.1016\/s0002-9440(10)64370-2.","journal-title":"The American Journal of Pathology"},{"issue":"9","key":"9874_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrurol.2013.168","volume":"10","author":"ZD Nassar","year":"2013","unstructured":"Nassar, Z. D., Hill, M. M., Parton, R. G., & Parat, M. O. (2013). Caveola-forming proteins caveolin-1 and PTRF in prostate cancer. Nature Reviews. Urology, 10(9), 529\u2013536. https:\/\/doi.org\/10.1038\/nrurol.2013.168.","journal-title":"Nature Reviews. Urology"},{"issue":"Pt 12","key":"9874_CR12","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1242\/jcs.086264","volume":"124","author":"Y Senju","year":"2011","unstructured":"Senju, Y., Itoh, Y., Takano, K., Hamada, S., & Suetsugu, S. (2011). Essential role of PACSIN2\/syndapin-II in caveolae membrane sculpting. Journal of Cell Science, 124(Pt 12), 2032\u20132040. https:\/\/doi.org\/10.1242\/jcs.086264.","journal-title":"Journal of Cell Science"},{"issue":"Pt 16","key":"9874_CR13","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1242\/jcs.084319","volume":"124","author":"CG Hansen","year":"2011","unstructured":"Hansen, C. G., Howard, G., & Nichols, B. J. (2011). Pacsin 2 is recruited to caveolae and functions in caveolar biogenesis. Journal of Cell Science, 124(Pt 16), 2777\u20132785. https:\/\/doi.org\/10.1242\/jcs.084319.","journal-title":"Journal of Cell Science"},{"issue":"8","key":"9874_CR14","doi-asserted-by":"publisher","first-page":"e1001640","DOI":"10.1371\/journal.pbio.1001640","volume":"11","author":"A Ludwig","year":"2013","unstructured":"Ludwig, A., Howard, G., Mendoza-Topaz, C., Deerinck, T., Mackey, M., Sandin, S., et al. (2013). Molecular composition and ultrastructure of the caveolar coat complex. PLoS Biology, 11(8), e1001640. https:\/\/doi.org\/10.1371\/journal.pbio.1001640.","journal-title":"PLoS Biology"},{"key":"9874_CR15","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1038\/ncomms10060","volume":"7","author":"T Yamaguchi","year":"2016","unstructured":"Yamaguchi, T., Lu, C., Ida, L., Yanagisawa, K., Usukura, J., Cheng, J., et al. (2016). ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nature Communications, 7, 10060. https:\/\/doi.org\/10.1038\/ncomms10060.","journal-title":"Nature Communications"},{"issue":"8","key":"9874_CR16","doi-asserted-by":"publisher","first-page":"R402","DOI":"10.1016\/j.cub.2017.11.075","volume":"28","author":"RG Parton","year":"2018","unstructured":"Parton, R. G., Tillu, V. A., & Collins, B. M. (2018). Caveolae. Current Biology, 28(8), R402\u2013r405. https:\/\/doi.org\/10.1016\/j.cub.2017.11.075.","journal-title":"Current Biology"},{"issue":"7","key":"9874_CR17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1083\/jcb.200903053","volume":"185","author":"M Bastiani","year":"2009","unstructured":"Bastiani, M., Liu, L., Hill, M. M., Jedrychowski, M. P., Nixon, S. J., Lo, H. P., et al. (2009). MURC\/Cavin-4 and cavin family members form tissue-specific caveolar complexes. The Journal of Cell Biology, 185(7), 1259\u20131273. https:\/\/doi.org\/10.1083\/jcb.200903053.","journal-title":"The Journal of Cell Biology"},{"issue":"8","key":"9874_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/emboj.2009.46","volume":"28","author":"K-A McMahon","year":"2009","unstructured":"McMahon, K.-A., Zajicek, H., Li, W.-P., Peyton, M. J., Minna, J. D., Hernandez, V. J., et al. (2009). SRBC\/cavin-3 is a caveolin adapter protein that regulates caveolae function. The EMBO Journal, 28(8), 1001\u20131015. https:\/\/doi.org\/10.1038\/emboj.2009.46.","journal-title":"The EMBO Journal"},{"issue":"7","key":"9874_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb1887","volume":"11","author":"CG Hansen","year":"2009","unstructured":"Hansen, C. G., Bright, N. A., Howard, G., & Nichols, B. J. (2009). SDPR induces membrane curvature and functions in the formation of caveolae. Nature Cell Biology, 11(7), 807\u2013814. https:\/\/doi.org\/10.1038\/ncb1887.","journal-title":"Nature Cell Biology"},{"issue":"9","key":"9874_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1600-0854.2005.00314.x","volume":"6","author":"AM Hommelgaard","year":"2005","unstructured":"Hommelgaard, A. M., Roepstorff, K., Vilhardt, F., Torgersen, M. L., Sandvig, K., & van Deurs, B. (2005). Caveolae: stable membrane domains with a potential for internalization. Traffic, 6(9), 720\u2013724. https:\/\/doi.org\/10.1111\/j.1600-0854.2005.00314.x.","journal-title":"Traffic"},{"key":"9874_CR21","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/978-0-387-74901-3_25","volume-title":"Drug absorption studies: in situ, in vitro and in silico models","author":"SA Ross","year":"2008","unstructured":"Ross, S. A., Everson, W. V., & Smart, E. J. (2008). The Pharmacology of caveolae. In C. Ehrhardt & K.-J. Kim (Eds.), Drug absorption studies: in situ, in vitro and in silico models (pp. 598\u2013615). Boston, MA: Springer US."},{"key":"9874_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jcp.10344","volume":"197","author":"E Spisni","year":"2003","unstructured":"Spisni, E., Bianco, M., Griffoni, C., Toni, M., D'Angelo, R., Santi, S., et al. (2003). Mechanosensing role of caveolae and caveolar constituents in human endothelial cells. Journal of Cellular Physiology, 197, 198\u2013204. https:\/\/doi.org\/10.1002\/jcp.10344.","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"9874_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490992.2015.1131891","volume":"6","author":"HP Lo","year":"2016","unstructured":"Lo, H. P., Hall, T. E., & Parton, R. G. (2016). Mechanoprotection by skeletal muscle caveolae. Bioarchitecture, 6(1), 22\u201327. https:\/\/doi.org\/10.1080\/19490992.2015.1131891.","journal-title":"Bioarchitecture"},{"issue":"10","key":"9874_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.molmed.2016.08.007","volume":"22","author":"MA Fernandez-Rojo","year":"2016","unstructured":"Fernandez-Rojo, M. A., & Ramm, G. A. (2016). Caveolin-1 function in liver physiology and disease. Trends in Molecular Medicine, 22(10), 889\u2013904. https:\/\/doi.org\/10.1016\/j.molmed.2016.08.007.","journal-title":"Trends in Molecular Medicine"},{"issue":"11","key":"9874_CR25","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.4161\/cc.4.11.2117","volume":"4","author":"J Li","year":"2005","unstructured":"Li, J., Scherl, A., Medina, F., Frank, P. G., Kitsis, R. N., Tanowitz, H. B., et al. (2005). Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle, 4(11), 1599\u20131607. https:\/\/doi.org\/10.4161\/cc.4.11.2117.","journal-title":"Cell Cycle"},{"issue":"Pt B","key":"9874_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.biochi.2014.09.010","volume":"107","author":"R Gupta","year":"2014","unstructured":"Gupta, R., Toufaily, C., & Annabi, B. (2014). Caveolin and cavin family members: dual roles in cancer. Biochimie, 107(Pt B), 188\u2013202. https:\/\/doi.org\/10.1016\/j.biochi.2014.09.010.","journal-title":"Biochimie"},{"key":"9874_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev-pathol-011811-120856","volume":"7","author":"F Sotgia","year":"2012","unstructured":"Sotgia, F., Martinez-Outschoorn, U. E., Howell, A., Pestell, R. G., Pavlides, S., & Lisanti, M. P. (2012). Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annual Review of Pathology, 7, 423\u2013467. https:\/\/doi.org\/10.1146\/annurev-pathol-011811-120856.","journal-title":"Annual Review of Pathology"},{"issue":"6","key":"9874_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/01913120600854079","volume":"30","author":"F Gallardo-Arrieta","year":"2006","unstructured":"Gallardo-Arrieta, F., Mogas, T., Magan, L., Garcia, M. A., Garcia, F., Abal, M., et al. (2006). Ultrastructural changes in prostate cells during hormone-induced canine prostatic hyperplasia. Ultrastructural Pathology, 30(6), 435\u2013442. https:\/\/doi.org\/10.1080\/01913120600854079.","journal-title":"Ultrastructural Pathology"},{"issue":"2-3","key":"9874_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.micron.2011.09.009","volume":"43","author":"MG Gobbo","year":"2012","unstructured":"Gobbo, M. G., Taboga, S. R., Ribeiro, D. L., & Goes, R. M. (2012). Short-term stromal alterations in the rat ventral prostate following alloxan-induced diabetes and the influence of insulin replacement. Micron, 43(2-3), 326\u2013333. https:\/\/doi.org\/10.1016\/j.micron.2011.09.009.","journal-title":"Micron"},{"issue":"15","key":"9874_CR30","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/pros.21195","volume":"70","author":"ML Gould","year":"2010","unstructured":"Gould, M. L., Williams, G., & Nicholson, H. D. (2010). Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression. The Prostate, 70(15), 1609\u20131621. https:\/\/doi.org\/10.1002\/pros.21195.","journal-title":"The Prostate"},{"issue":"1","key":"9874_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/jcb.23358","volume":"113","author":"L Bai","year":"2012","unstructured":"Bai, L., Deng, X., Li, Q., Wang, M., An, W., Deli, A., et al. (2012). Down-regulation of the cavin family proteins in breast cancer. Journal of Cellular Biochemistry, 113(1), 322\u2013328. https:\/\/doi.org\/10.1002\/jcb.23358.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"7","key":"9874_CR32","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1111\/j.1349-7006.2008.00816.x","volume":"99","author":"X Li","year":"2008","unstructured":"Li, X., Jia, Z., Shen, Y., Ichikawa, H., Jarvik, J., Nagele, R. G., et al. (2008). Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate. Cancer Science, 99(7), 1326\u20131333. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00816.x.","journal-title":"Cancer Science"},{"issue":"3","key":"9874_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/cas.12879","volume":"107","author":"Y Tian","year":"2016","unstructured":"Tian, Y., Yu, Y., Hou, L. K., Chi, J. R., Mao, J. F., Xia, L., et al. (2016). Serum deprivation response inhibits breast cancer progression by blocking transforming growth factor-beta signaling. Cancer Science, 107(3), 274\u2013280. https:\/\/doi.org\/10.1111\/cas.12879.","journal-title":"Cancer Science"},{"issue":"3","key":"9874_CR34","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1073\/pnas.1514663113","volume":"113","author":"S Ozturk","year":"2016","unstructured":"Ozturk, S., Papageorgis, P., Wong, C. K., Lambert, A. W., Abdolmaleky, H. M., Thiagalingam, A., et al. (2016). SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 113(3), 638\u2013643. https:\/\/doi.org\/10.1073\/pnas.1514663113.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"9874_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10735-015-9614-7","volume":"46","author":"Y Shi","year":"2015","unstructured":"Shi, Y., Liu, X., Sun, Y., Wu, D., Qiu, A., Cheng, H., et al. (2015). Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin. Journal of Molecular Histology, 46(2), 221\u2013231. https:\/\/doi.org\/10.1007\/s10735-015-9614-7.","journal-title":"Journal of Molecular Histology"},{"issue":"5","key":"9874_CR36","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1007\/s13277-014-3011-9","volume":"36","author":"X Yang","year":"2015","unstructured":"Yang, X., Ren, H., Yao, L., Chen, X., & He, A. (2015). Role of EHD2 in migration and invasion of human breast cancer cells. Tumour Biology, 36(5), 3717\u20133726. https:\/\/doi.org\/10.1007\/s13277-014-3011-9.","journal-title":"Tumour Biology"},{"issue":"3","key":"9874_CR37","doi-asserted-by":"publisher","first-page":"e31127","DOI":"10.1371\/journal.pone.0031127","volume":"7","author":"S Zhang","year":"2012","unstructured":"Zhang, S., Chen, L., Cui, B., Chuang, H. Y., Yu, J., Wang-Rodriguez, J., et al. (2012). ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth. PLoS One, 7(3), e31127. https:\/\/doi.org\/10.1371\/journal.pone.0031127.","journal-title":"PLoS One"},{"issue":"5","key":"9874_CR38","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00428-016-1911-3","volume":"468","author":"HP Chien","year":"2016","unstructured":"Chien, H. P., Ueng, S. H., Chen, S. C., Chang, Y. S., Lin, Y. C., Lo, Y. F., et al. (2016). Expression of ROR1 has prognostic significance in triple negative breast cancer. Virchows Archiv, 468(5), 589\u2013595. https:\/\/doi.org\/10.1007\/s00428-016-1911-3.","journal-title":"Virchows Archiv"},{"issue":"4","key":"9874_CR39","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1073\/pnas.1816262116","volume":"116","author":"S Zhang","year":"2019","unstructured":"Zhang, S., Zhang, H., Ghia, E. M., Huang, J., Wu, L., Zhang, J., et al. (2019). Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody. Proceedings of the National Academy of Sciences of the United States of America, 116(4), 1370\u20131377. https:\/\/doi.org\/10.1073\/pnas.1816262116.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9874_CR40","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/srep05811","volume":"4","author":"H Zhang","year":"2014","unstructured":"Zhang, H., Qiu, J., Ye, C., Yang, D., Gao, L., Su, Y., et al. (2014). ROR1 expression correlated with poor clinical outcome in human ovarian cancer. Scientific Reports, 4, 5811. https:\/\/doi.org\/10.1038\/srep05811.","journal-title":"Scientific Reports"},{"issue":"55","key":"9874_CR41","doi-asserted-by":"publisher","first-page":"94210","DOI":"10.18632\/oncotarget.21618","volume":"8","author":"Z Yin","year":"2017","unstructured":"Yin, Z., Gao, M., Chu, S., Su, Y., Ye, C., Wang, Y., et al. (2017). Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells. Oncotarget, 8(55), 94210\u201394222. https:\/\/doi.org\/10.18632\/oncotarget.21618.","journal-title":"Oncotarget"},{"issue":"37","key":"9874_CR42","doi-asserted-by":"publisher","first-page":"40310","DOI":"10.18632\/oncotarget.5643","volume":"6","author":"C Henry","year":"2015","unstructured":"Henry, C., Llamosas, E., Knipprath-Meszaros, A., Schoetzau, A., Obermann, E., Fuenfschilling, M., et al. (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. Oncotarget, 6(37), 40310\u201340326. https:\/\/doi.org\/10.18632\/oncotarget.5643.","journal-title":"Oncotarget"},{"issue":"5","key":"9874_CR43","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1038\/oncsis.2016.32","volume":"5","author":"CE Henry","year":"2016","unstructured":"Henry, C. E., Llamosas, E., Djordjevic, A., Hacker, N. F., & Ford, C. E. (2016). Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer. Oncogenesis, 5(5), e226. https:\/\/doi.org\/10.1038\/oncsis.2016.32.","journal-title":"Oncogenesis"},{"issue":"48","key":"9874_CR44","doi-asserted-by":"publisher","first-page":"17266","DOI":"10.1073\/pnas.1419599111","volume":"111","author":"S Zhang","year":"2014","unstructured":"Zhang, S., Cui, B., Lai, H., Liu, G., Ghia, E. M., Widhopf 2nd, G. F., et al. (2014). Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy. Proceedings of the National Academy of Sciences of the United States of America, 111(48), 17266\u201317271. https:\/\/doi.org\/10.1073\/pnas.1419599111.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"9874_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ygyno.2018.01.025","volume":"148","author":"CE Henry","year":"2018","unstructured":"Henry, C. E., Llamosas, E., Daniels, B., Coopes, A., Tang, K., & Ford, C. E. (2018). ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. Gynecologic Oncology, 148(3), 576\u2013584. https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.025.","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"9874_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12894-018-0418-4","volume":"18","author":"X Wang","year":"2018","unstructured":"Wang, X., Liu, Z., & Yang, Z. (2018). Expression and clinical significance of Caveolin-1 in prostate cancer after transurethral surgery. BMC Urology, 18(1), 102. https:\/\/doi.org\/10.1186\/s12894-018-0418-4.","journal-title":"BMC Urology"},{"issue":"6","key":"9874_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/pros.20557","volume":"67","author":"JA Karam","year":"2007","unstructured":"Karam, J. A., Lotan, Y., Roehrborn, C. G., Ashfaq, R., Karakiewicz, P. I., & Shariat, S. F. (2007). Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. The Prostate, 67(6), 614\u2013622. https:\/\/doi.org\/10.1002\/pros.20557.","journal-title":"The Prostate"},{"issue":"1","key":"9874_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.urology.2007.11.003","volume":"72","author":"T Goto","year":"2008","unstructured":"Goto, T., Nguyen, B. P., Nakano, M., Ehara, H., Yamamoto, N., & Deguchi, T. (2008). Utility of Bcl-2, P53, Ki-67, and caveolin-1 immunostaining in the prediction of biochemical failure after radical prostatectomy in a Japanese population. Urology, 72(1), 167\u2013171. https:\/\/doi.org\/10.1016\/j.urology.2007.11.003.","journal-title":"Urology"},{"issue":"1","key":"9874_CR49","doi-asserted-by":"publisher","first-page":"41138","DOI":"10.1038\/srep41138","volume":"7","author":"A Panic","year":"2017","unstructured":"Panic, A., Ketteler, J., Reis, H., Sak, A., Herskind, C., Maier, P., et al. (2017). Progression-related loss of stromal caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance. Scientific Reports, 7(1), 41138. https:\/\/doi.org\/10.1038\/srep41138.","journal-title":"Scientific Reports"},{"issue":"5","key":"9874_CR50","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1038\/oncsis.2015.9","volume":"4","author":"D Klein","year":"2015","unstructured":"Klein, D., Schmitz, T., Verhelst, V., Panic, A., Schenck, M., Reis, H., et al. (2015). Endothelial caveolin-1 regulates the radiation response of epithelial prostate tumors. Oncogenesis, 4(5), e148\u2013e148. https:\/\/doi.org\/10.1038\/oncsis.2015.9.","journal-title":"Oncogenesis"},{"issue":"1","key":"9874_CR51","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1038\/s41598-018-20161-2","volume":"8","author":"T Pellinen","year":"2018","unstructured":"Pellinen, T., Blom, S., S\u00e1nchez, S., V\u00e4lim\u00e4ki, K., Mpindi, J.-P., Azegrouz, H., et al. (2018). ITGB1-dependent upregulation of caveolin-1 switches TGF\u03b2 signalling from tumour-suppressive to oncogenic in prostate cancer. Scientific Reports, 8(1), 2338. https:\/\/doi.org\/10.1038\/s41598-018-20161-2.","journal-title":"Scientific Reports"},{"issue":"2","key":"9874_CR52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1158\/1541-7786.MCR-11-0451","volume":"10","author":"G Yang","year":"2012","unstructured":"Yang, G., Goltsov, A. A., Ren, C., Kurosaka, S., Edamura, K., Logothetis, R., et al. (2012). Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer. Molecular Cancer Research, 10(2), 218\u2013229. https:\/\/doi.org\/10.1158\/1541-7786.MCR-11-0451.","journal-title":"Molecular Cancer Research"},{"issue":"24","key":"9874_CR53","first-page":"6370","volume":"54","author":"JC Zenklusen","year":"1994","unstructured":"Zenklusen, J. C., Thompson, J. C., Troncoso, P., Kagan, J., & Conti, C. J. (1994). Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31. 1. Cancer Research, 54(24), 6370.","journal-title":"Cancer Research"},{"issue":"13","key":"9874_CR54","first-page":"3574","volume":"54","author":"S Takahashi","year":"1994","unstructured":"Takahashi, S., Qian, J., Brown, J. A., Alcaraz, A., Bostwick, D. G., Lieber, M. M., et al. (1994). Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Research, 54(13), 3574.","journal-title":"Cancer Research"},{"issue":"18","key":"9874_CR55","first-page":"4114","volume":"55","author":"S Takahashi","year":"1995","unstructured":"Takahashi, S., Shan, A. L., Ritland, S. R., Delacey, K. A., Bostwick, D. G., Lieber, M. M., et al. (1995). Frequent loss of heterozygosity at 7q31. 1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Research, 55(18), 4114.","journal-title":"Cancer Research"},{"issue":"3","key":"9874_CR56","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/s0014-5793(98)00619-x","volume":"429","author":"JA Engelman","year":"1998","unstructured":"Engelman, J. A., Zhang, X. L., Galbiati, F., & Lisanti, M. P. (1998). Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2\/7q31). FEBS Letters, 429(3), 330\u2013336. https:\/\/doi.org\/10.1016\/s0014-5793(98)00619-x.","journal-title":"FEBS Letters"},{"issue":"13","key":"9874_CR57","first-page":"3091","volume":"56","author":"ML Cher","year":"1996","unstructured":"Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., et al. (1996). Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Research, 56(13), 3091.","journal-title":"Cancer Research"},{"issue":"4","key":"9874_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/gcc.2870140405","volume":"14","author":"S Joos","year":"1995","unstructured":"Joos, S., Bergerheim, U. S. R., Pan, Y., Matsuyama, H., Bentz, M., Manoir, S. D., et al. (1995). Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes, Chromosomes and Cancer, 14(4), 267\u2013276.","journal-title":"Genes, Chromosomes and Cancer"},{"issue":"2","key":"9874_CR59","first-page":"342","volume":"55","author":"T Visakorpi","year":"1995","unstructured":"Visakorpi, T., Kallioniemi, A. H., Syv\u00e4nen, A. C., Hyytinen, E. R., Karhu, R., Tammela, T., et al. (1995). Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Research, 55(2), 342\u2013347.","journal-title":"Cancer Research"},{"issue":"4","key":"9874_CR60","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/sj.pcan.4500826","volume":"8","author":"N Brookman-Amissah","year":"2005","unstructured":"Brookman-Amissah, N., Duchesnes, C., Williamson, M., Wang, Q., Ahmed, A., Feneley, M., et al. (2005). Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH. Prostate Cancer and Prostatic Diseases, 8(4), 335\u2013343.","journal-title":"Prostate Cancer and Prostatic Diseases"},{"issue":"1","key":"9874_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0002-9440(10)65554-X","volume":"153","author":"NN Nupponen","year":"1998","unstructured":"Nupponen, N. N., Kakkola, L., Koivisto, P., & Visakorpi, T. (1998). Genetic alterations in hormone-refractory recurrent prostate carcinomas. The American Journal of Pathology, 153(1), 141\u2013148. https:\/\/doi.org\/10.1016\/S0002-9440(10)65554-X.","journal-title":"The American Journal of Pathology"},{"issue":"1","key":"9874_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/gcc.2870090105","volume":"9","author":"MG Bandyk","year":"1994","unstructured":"Bandyk, M. G., Pisters, L. L., Von Eshenbach, A. C., Chung, L. W. K., Zhao, L., Liang, J. C., et al. (1994). Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes, Chromosomes and Cancer, 9(1), 19\u201327.","journal-title":"Genes, Chromosomes and Cancer"},{"issue":"4","key":"9874_CR63","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/path.1711720407","volume":"172","author":"H Zitzelsberger","year":"1994","unstructured":"Zitzelsberger, H., Sz\u00fccs, S., Weier, H. U., Lehmann, L., Braselmann, H., Enders, S., et al. (1994). Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific dna probes. The Journal of Pathology, 172(4), 325\u2013335.","journal-title":"The Journal of Pathology"},{"issue":"1","key":"9874_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1399-0004.2005.00452.x","volume":"68","author":"K Das","year":"2005","unstructured":"Das, K., Lau, W., Sivaswaren, C., Ph, T., Fook-Chong, S., Sl, T., et al. (2005). Chromosomal changes in prostate cancer: a fluorescence in situ hybridization study. Clinical Genetics, 68(1), 40\u201347. https:\/\/doi.org\/10.1111\/j.1399-0004.2005.00452.x.","journal-title":"Clinical Genetics"},{"issue":"15","key":"9874_CR65","first-page":"3998","volume":"54","author":"A Alcaraz","year":"1994","unstructured":"Alcaraz, A., Takahashi, S., Brown, J. A., Herath, J. F., Bergstralh, E. J., Larson-Keller, J. J., et al. (1994). Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Research, 54(15), 3998\u20134002.","journal-title":"Cancer Research"},{"issue":"7","key":"9874_CR66","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0046-8177(96)90404-9","volume":"27","author":"JJ Konig","year":"1996","unstructured":"Konig, J. J., Teubel, W., Romijn, J. C., Schroder, F. H., & Hagemeijer, A. (1996). Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers. Human Pathology, 27(7), 720\u2013727.","journal-title":"Human Pathology"},{"issue":"4","key":"9874_CR67","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1152\/physrev.00046.2003","volume":"84","author":"AW Cohen","year":"2004","unstructured":"Cohen, A. W., Hnasko, R., Schubert, W., & Lisanti, M. P. (2004). Role of caveolae and caveolins in health and disease. Physiological Reviews, 84(4), 1341\u20131379.","journal-title":"Physiological Reviews"},{"issue":"2","key":"9874_CR68","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/pros.20256","volume":"65","author":"J Haeusler","year":"2005","unstructured":"Haeusler, J., Hoegel, J., Bachmann, N., Herkommer, K., Paiss, T., Vogel, W., et al. (2005). Association of a CAV-1 haplotype to familial aggressive prostate cancer. The Prostate, 65(2), 171\u2013177.","journal-title":"The Prostate"},{"issue":"3","key":"9874_CR69","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/1097-0045(20010215)46:3<249::AID-PROS1030>3.0.CO;2-#","volume":"46","author":"J Cui","year":"2001","unstructured":"Cui, J., Rohr, L. R., Swanson, G., Speights, V., Maxwell, T., & Brothma, A. R. (2001). Hypermethylation of the caveolin-1 gene promoter in prostate cancer. The Prostate, 46(3), 249\u2013256.","journal-title":"The Prostate"},{"issue":"2","key":"9874_CR70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cancergencyto.2008.01.006","volume":"182","author":"N Bachmann","year":"2008","unstructured":"Bachmann, N., Haeusler, J., Luedeke, M., Kuefer, R., Perner, S., Assum, G., et al. (2008). Expression changes of CAV1 and EZH2, located on 7q31\u223cq36, are rarely related to genomic alterations in primary prostate carcinoma. Cancer Genetics and Cytogenetics, 182(2), 103\u2013110. https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.01.006.","journal-title":"Cancer Genetics and Cytogenetics"},{"issue":"2","key":"9874_CR71","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2003.11.027","volume":"205","author":"K Woodson","year":"2004","unstructured":"Woodson, K., Hanson, J., & Tangrea, J. (2004). A survey of gene-specific methylation in human prostate cancer among black and white men. Cancer Letters, 205(2), 181\u2013188. https:\/\/doi.org\/10.1016\/j.canlet.2003.11.027.","journal-title":"Cancer Letters"},{"issue":"1","key":"9874_CR72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/pcan.2009.29","volume":"13","author":"TC Thompson","year":"2010","unstructured":"Thompson, T. C., Tahir, S. A., Li, L., Watanabe, M., Naruishi, K., Yang, G., et al. (2010). The role of caveolin-1 in prostate cancer: clinical implications. Prostate Cancer and Prostatic Diseases, 13(1), 6\u201311. https:\/\/doi.org\/10.1038\/pcan.2009.29.","journal-title":"Prostate Cancer and Prostatic Diseases"},{"issue":"10","key":"9874_CR73","first-page":"3882","volume":"61","author":"SA Tahir","year":"2001","unstructured":"Tahir, S. A., Yang, G., Ebara, S., Timme, T. L., Satoh, T., Li, L., et al. (2001). Secreted caveolin-1 stimulates cell survival\/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Research, 61(10), 3882\u20133885.","journal-title":"Cancer Research"},{"issue":"5","key":"9874_CR74","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/cncr.11198","volume":"97","author":"T Satoh","year":"2003","unstructured":"Satoh, T., Yang, G., Egawa, S., Addai, J., Frolov, A., Kuwao, S., et al. (2003). Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients. Cancer, 97(5), 1225\u20131233. https:\/\/doi.org\/10.1002\/cncr.11198.","journal-title":"Cancer"},{"issue":"6","key":"9874_CR75","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/cncr.20905","volume":"103","author":"G Yang","year":"2005","unstructured":"Yang, G., Timme, T. L., Frolov, A., Wheeler, T. M., & Thompson, T. C. (2005). Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Cancer, 103(6), 1186\u20131194. https:\/\/doi.org\/10.1002\/cncr.20905.","journal-title":"Cancer"},{"issue":"27","key":"9874_CR76","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1038\/onc.2013.315","volume":"33","author":"H Moon","year":"2014","unstructured":"Moon, H., Lee, C. S., Inder, K. L., Sharma, S., Choi, E., Black, D. M., et al. (2014). PTRF\/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer. Oncogene, 33(27), 3561\u20133570. https:\/\/doi.org\/10.1038\/onc.2013.315.","journal-title":"Oncogene"},{"issue":"10","key":"9874_CR77","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.18632\/oncotarget.1300","volume":"4","author":"ZD Nassar","year":"2013","unstructured":"Nassar, Z. D., Moon, H., Duong, T., Neo, L., Hill, M. M., Francois, M., et al. (2013). PTRF\/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis. Oncotarget, 4(10), 1844\u20131855. https:\/\/doi.org\/10.18632\/oncotarget.1300.","journal-title":"Oncotarget"},{"issue":"6","key":"9874_CR78","first-page":"391","volume":"12","author":"S Sugie","year":"2015","unstructured":"Sugie, S., Mukai, S., Yamasaki, K., Kamibeppu, T., Tsukino, H., & Kamoto, T. (2015). Significant association of caveolin-1 and caveolin-2 with prostate cancer progression. Cancer Genomics Proteomics, 12(6), 391\u2013396.","journal-title":"Cancer Genomics Proteomics"},{"issue":"6","key":"9874_CR79","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/14067","volume":"1","author":"P Liu","year":"1999","unstructured":"Liu, P., Li, W. P., Machleidt, T., & Anderson, R. G. (1999). Identification of caveolin-1 in lipoprotein particles secreted by exocrine cells. Nature Cell Biology, 1(6), 369\u2013375. https:\/\/doi.org\/10.1038\/14067.","journal-title":"Nature Cell Biology"},{"issue":"3","key":"9874_CR80","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/humupd\/dmi052","volume":"12","author":"HP Burden","year":"2005","unstructured":"Burden, H. P., Holmes, C. H., Persad, R., & Whittington, K. (2005). Prostasomes\u2014their effects on human male reproduction and fertility. Human Reproduction Update, 12(3), 283\u2013292. https:\/\/doi.org\/10.1093\/humupd\/dmi052.","journal-title":"Human Reproduction Update"},{"issue":"Pt 22","key":"9874_CR81","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1242\/jcs.01420","volume":"117","author":"A Llorente","year":"2004","unstructured":"Llorente, A., de Marco, M. C., & Alonso, M. A. (2004). Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line. Journal of Cell Science, 117(Pt 22), 5343\u20135351. https:\/\/doi.org\/10.1242\/jcs.01420.","journal-title":"Journal of Cell Science"},{"issue":"3","key":"9874_CR82","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ijc.23142","volume":"122","author":"R Bartz","year":"2008","unstructured":"Bartz, R., Zhou, J., Hsieh, J.-T., Ying, Y., Li, W., & Liu, P. (2008). Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo. International Journal of Cancer, 122(3), 520\u2013525. https:\/\/doi.org\/10.1002\/ijc.23142.","journal-title":"International Journal of Cancer"},{"issue":"5","key":"9874_CR83","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.ajpath.2012.07.030","volume":"181","author":"D Di Vizio","year":"2012","unstructured":"Di Vizio, D., Morello, M., Dudley, A. C., Schow, P. W., Adam, R. M., Morley, S., et al. (2012). Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. The American Journal of Pathology, 181(5), 1573\u20131584. https:\/\/doi.org\/10.1016\/j.ajpath.2012.07.030.","journal-title":"The American Journal of Pathology"},{"issue":"11","key":"9874_CR84","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41419-019-2066-3","volume":"10","author":"CJ Lin","year":"2019","unstructured":"Lin, C. J., Yun, E. J., Lo, U. G., Tai, Y. L., Deng, S., Hernandez, E., et al. (2019). The paracrine induction of prostate cancer progression by caveolin-1. Cell Death & Disease, 10(11), 834. https:\/\/doi.org\/10.1038\/s41419-019-2066-3.","journal-title":"Cell Death & Disease"},{"issue":"10","key":"9874_CR85","first-page":"3653","volume":"9","author":"SA Tahir","year":"2003","unstructured":"Tahir, S. A., Ren, C., Timme, T. L., Gdor, Y., Hoogeveen, R., Morrisett, J. D., et al. (2003). Development of an immunoassay for serum caveolin-1 a novel biomarker for prostate cancer. Clinical Cancer Research, 9(10), 3653\u20133659.","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"9874_CR86","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4161\/cbt.22633","volume":"14","author":"SA Tahir","year":"2013","unstructured":"Tahir, S. A., Kurosaka, S., Tanimoto, R., Goltsov, A. A., Park, S., & Thompson, T. C. (2013). Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models. Cancer Biology & Therapy, 14(2), 117\u2013126. https:\/\/doi.org\/10.4161\/cbt.22633.","journal-title":"Cancer Biology & Therapy"},{"issue":"16","key":"9874_CR87","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1158\/1078-0432.CCR-06-0417","volume":"12","author":"SA Tahir","year":"2006","unstructured":"Tahir, S. A., Frolov, A., Hayes, T. G., Mims, M. P., Miles, B. J., Lerner, S. P., et al. (2006). Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clinical Cancer Research, 12(16), 4872\u20134875.","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"9874_CR88","first-page":"1893","volume":"33","author":"S Sugie","year":"2013","unstructured":"Sugie, S., Mukai, S., Tsukino, H., Toda, Y., Yamauchi, T., Nishikata, I., et al. (2013). Increased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese men. Anticancer Research, 33(5), 1893\u20131897.","journal-title":"Anticancer Research"},{"issue":"11","key":"9874_CR89","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.humpath.2007.03.024","volume":"38","author":"G Yang","year":"2007","unstructured":"Yang, G., Addai, J., Wheeler, T. M., Frolov, A., Miles, B. J., Kadmon, D., et al. (2007). Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Human Pathology, 38(11), 1688\u20131695. https:\/\/doi.org\/10.1016\/j.humpath.2007.03.024.","journal-title":"Human Pathology"},{"issue":"2","key":"9874_CR90","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/bju.13224","volume":"118","author":"R Mathieu","year":"2016","unstructured":"Mathieu, R., Klatte, T., Lucca, I., Mbeutcha, A., Seitz, C., Karakiewicz, P. I., et al. (2016). Prognostic value of caveolin-1 in patients treated with radical prostatectomy: a multicentric validation study. BJU International, 118(2), 243\u2013249. https:\/\/doi.org\/10.1111\/bju.13224.","journal-title":"BJU International"},{"issue":"8","key":"9874_CR91","first-page":"1873","volume":"4","author":"G Yang","year":"1998","unstructured":"Yang, G., Truong, L. D., Timme, T. L., Ren, C., Wheeler, T. M., Park, S. H., et al. (1998). Elevated expression of caveolin is associated with prostate and breast cancer. Clinical Cancer Research, 4(8), 1873\u20131880.","journal-title":"Clinical Cancer Research"},{"issue":"22","key":"9874_CR92","first-page":"5719","volume":"59","author":"G Yang","year":"1999","unstructured":"Yang, G., Truong, L. D., Wheeler, T. M., & Thompson, T. C. (1999). Caveolin-1 expression in clinically confined human prostate cancer. Cancer Research, 59(22), 5719.","journal-title":"Cancer Research"},{"issue":"11","key":"9874_CR93","first-page":"20760","volume":"8","author":"JM Liu","year":"2015","unstructured":"Liu, J. M., Cheng, S. H., Liu, X. X., Xia, C., Wang, W. W., & Ma, X. L. (2015). Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis. International Journal of Clinical and Experimental Medicine, 8(11), 20760\u201320768.","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"1","key":"9874_CR94","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/bju.13963","volume":"121","author":"SP Basourakos","year":"2018","unstructured":"Basourakos, S. P., Davis, J. W., Chapin, B. F., Ward, J. F., Pettaway, C. A., Pisters, L. L., et al. (2018). Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU International, 121(1), 69\u201376. https:\/\/doi.org\/10.1111\/bju.13963.","journal-title":"BJU International"},{"issue":"4","key":"9874_CR95","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu, P., Weaver, V. M., & Werb, Z. (2012). The extracellular matrix: a dynamic niche in cancer progression. The Journal of Cell Biology, 196(4), 395\u2013406. https:\/\/doi.org\/10.1083\/jcb.201102147.","journal-title":"The Journal of Cell Biology"},{"issue":"1","key":"9874_CR96","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1741-7015-4-38","volume":"4","author":"PP Provenzano","year":"2006","unstructured":"Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G., & Keely, P. J. (2006). Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Medicine, 4(1), 38. https:\/\/doi.org\/10.1186\/1741-7015-4-38.","journal-title":"BMC Medicine"},{"issue":"5","key":"9874_CR97","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., et al. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell, 139(5), 891\u2013906. https:\/\/doi.org\/10.1016\/j.cell.2009.10.027.","journal-title":"Cell"},{"issue":"6","key":"9874_CR98","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","volume":"18","author":"M Egeblad","year":"2010","unstructured":"Egeblad, M., Nakasone, E. S., & Werb, Z. (2010). Tumors as organs: complex tissues that interface with the entire organism. Developmental Cell, 18(6), 884\u2013901. https:\/\/doi.org\/10.1016\/j.devcel.2010.05.012.","journal-title":"Developmental Cell"},{"issue":"1","key":"9874_CR99","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes, R. M., Donnem, T., Al-Saad, S., Al-Shibli, K., Andersen, S., Sirera, R., et al. (2011). The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. Journal of Thoracic Oncology, 6(1), 209\u2013217. https:\/\/doi.org\/10.1097\/JTO.0b013e3181f8a1bd.","journal-title":"Journal of Thoracic Oncology"},{"issue":"15","key":"9874_CR100","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.4161\/cc.8.15.9116","volume":"8","author":"D Di Vizio","year":"2009","unstructured":"Di Vizio, D., Morello, M., Sotgia, F., Pestell, R. G., Freeman, M. R., & Lisanti, M. P. (2009). An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle, 8(15), 2420\u20132424. https:\/\/doi.org\/10.4161\/cc.8.15.9116.","journal-title":"Cell Cycle"},{"issue":"13","key":"9874_CR101","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.4161\/cbt.21785","volume":"13","author":"A Giatromanolaki","year":"2012","unstructured":"Giatromanolaki, A., Koukourakis, M. I., Koutsopoulos, A., Mendrinos, S., & Sivridis, E. (2012). The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer. Cancer Biology & Therapy, 13(13), 1284\u20131289. https:\/\/doi.org\/10.4161\/cbt.21785.","journal-title":"Cancer Biology & Therapy"},{"key":"9874_CR102","doi-asserted-by":"publisher","first-page":"41138","DOI":"10.1038\/srep41138","volume":"7","author":"A Panic","year":"2017","unstructured":"Panic, A., Ketteler, J., Reis, H., Sak, A., Herskind, C., Maier, P., et al. (2017). Progression-related loss of stromal caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance. Scientific Reports, 7, 41138. https:\/\/doi.org\/10.1038\/srep41138.","journal-title":"Scientific Reports"},{"issue":"18","key":"9874_CR103","doi-asserted-by":"publisher","first-page":"16757","DOI":"10.18632\/oncotarget.4430","volume":"6","author":"J Zhu","year":"2015","unstructured":"Zhu, J., Pan, C., Jiang, J., Deng, M., Gao, H., Men, B., et al. (2015). Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China. Oncotarget, 6(18), 16757\u201316765. https:\/\/doi.org\/10.18632\/oncotarget.4430.","journal-title":"Oncotarget"},{"issue":"1","key":"9874_CR104","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/path.4217","volume":"231","author":"G Ayala","year":"2013","unstructured":"Ayala, G., Morello, M., Frolov, A., You, S., Li, R., Rosati, F., et al. (2013). Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. The Journal of Pathology, 231(1), 77\u201387. https:\/\/doi.org\/10.1002\/path.4217.","journal-title":"The Journal of Pathology"},{"issue":"10","key":"9874_CR105","doi-asserted-by":"publisher","first-page":"e0164016","DOI":"10.1371\/journal.pone.0164016","volume":"11","author":"P Hammarsten","year":"2016","unstructured":"Hammarsten, P., Dahl Scherdin, T., Hagglof, C., Andersson, P., Wikstrom, P., Stattin, P., et al. (2016). High caveolin-1 expression in tumor stroma is associated with a favourable outcome in prostate cancer patients managed by watchful waiting. PLoS One, 11(10), e0164016. https:\/\/doi.org\/10.1371\/journal.pone.0164016.","journal-title":"PLoS One"},{"issue":"16","key":"9874_CR106","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.4161\/cc.9.16.12553","volume":"9","author":"UE Martinez-Outschoorn","year":"2010","unstructured":"Martinez-Outschoorn, U. E., Balliet, R. M., Rivadeneira, D. B., Chiavarina, B., Pavlides, S., Wang, C., et al. (2010). Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle, 9(16), 3256\u20133276. https:\/\/doi.org\/10.4161\/cc.9.16.12553.","journal-title":"Cell Cycle"},{"issue":"15","key":"9874_CR107","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.4161\/cc.10.15.16585","volume":"10","author":"UE Martinez-Outschoorn","year":"2011","unstructured":"Martinez-Outschoorn, U. E., Lin, Z., Trimmer, C., Flomenberg, N., Wang, C., Pavlides, S., et al. (2011). Cancer cells metabolically \u201cfertilize\u201d the tumor microenvironment with hydrogen peroxide, driving the Warburg effect: implications for PET imaging of human tumors. Cell Cycle, 10(15), 2504\u20132520. https:\/\/doi.org\/10.4161\/cc.10.15.16585.","journal-title":"Cell Cycle"},{"key":"9874_CR108","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","volume":"25","author":"UE Martinez-Outschoorn","year":"2014","unstructured":"Martinez-Outschoorn, U. E., Lisanti, M. P., & Sotgia, F. (2014). Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Seminars in Cancer Biology, 25, 47\u201360. https:\/\/doi.org\/10.1016\/j.semcancer.2014.01.005.","journal-title":"Seminars in Cancer Biology"},{"key":"9874_CR109","doi-asserted-by":"publisher","unstructured":"Ketteler, J., Panic, A., Reis, H., Wittka, A., Maier, P., Herskind, C., et al. (2019). Progression-related loss of stromal caveolin 1 levels mediates radiation resistance in prostate carcinoma via the apoptosis inhibitor TRIAP1. Journal of Clinical Medicine, 8(3). https:\/\/doi.org\/10.3390\/jcm8030348.","DOI":"10.3390\/jcm8030348"},{"issue":"3","key":"9874_CR110","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3978\/j.issn.2223-4683.2013.09.16","volume":"2","author":"EA Mostaghel","year":"2013","unstructured":"Mostaghel, E. A. (2013). Steroid hormone synthetic pathways in prostate cancer. Translational Andrology and Urology, 2(3), 212\u2013227. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2013.09.16.","journal-title":"Translational Andrology and Urology"},{"issue":"16","key":"9874_CR111","doi-asserted-by":"publisher","first-page":"13442","DOI":"10.1074\/jbc.M006598200","volume":"276","author":"ML Lu","year":"2001","unstructured":"Lu, M. L., Schneider, M. C., Zheng, Y., Zhang, X., & Richie, J. P. (2001). Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. The Journal of Biological Chemistry, 276(16), 13442\u201313451. https:\/\/doi.org\/10.1074\/jbc.M006598200.","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"9874_CR112","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/pros.22767","volume":"74","author":"NC Bennett","year":"2014","unstructured":"Bennett, N. C., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2014). Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines. Prostate, 74(5), 478\u2013487. https:\/\/doi.org\/10.1002\/pros.22767.","journal-title":"Prostate"},{"issue":"4","key":"9874_CR113","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(sici)1097-0045(19990901)40:4<269::aid-pros9>3.0.co;2-6","volume":"40","author":"BR Pflug","year":"1999","unstructured":"Pflug, B. R., Reiter, R. E., & Nelson, J. B. (1999). Caveolin expression is decreased following androgen deprivation in human prostate cancer cell lines. Prostate, 40(4), 269\u2013273. https:\/\/doi.org\/10.1002\/(sici)1097-0045(19990901)40:4<269::aid-pros9>3.0.co;2-6.","journal-title":"Prostate"},{"issue":"11","key":"9874_CR114","first-page":"4386","volume":"61","author":"L Li","year":"2001","unstructured":"Li, L., Yang, G., Ebara, S., Satoh, T., Nasu, Y., Timme, T. L., et al. (2001). Caveolin-1 mediates testosterone-stimulated survival\/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Research, 61(11), 4386\u20134392.","journal-title":"Cancer Research"},{"issue":"9","key":"9874_CR115","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.biocel.2011.04.019","volume":"43","author":"KG Bryant","year":"2011","unstructured":"Bryant, K. G., Camacho, J., Jasmin, J. F., Wang, C., Addya, S., Casimiro, M. C., et al. (2011). Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate. The International Journal of Biochemistry & Cell Biology, 43(9), 1318\u20131329. https:\/\/doi.org\/10.1016\/j.biocel.2011.04.019.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"24","key":"9874_CR116","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1128\/mcb.23.24.9389-9404.2003","volume":"23","author":"L Li","year":"2003","unstructured":"Li, L., Ren, C. H., Tahir, S. A., Ren, C., & Thompson, T. C. (2003). Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine\/threonine protein phosphatases PP1 and PP2A. Molecular and Cellular Biology, 23(24), 9389\u20139404. https:\/\/doi.org\/10.1128\/mcb.23.24.9389-9404.2003.","journal-title":"Molecular and Cellular Biology"},{"issue":"9","key":"9874_CR117","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/2048","volume":"4","author":"Y Nasu","year":"1998","unstructured":"Nasu, Y., Timme, T. L., Yang, G., Bangma, C. H., Li, L., Ren, C., et al. (1998). Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nature Medicine, 4(9), 1062\u20131064. https:\/\/doi.org\/10.1038\/2048.","journal-title":"Nature Medicine"},{"issue":"6","key":"9874_CR118","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3892\/ijo.2019.4774","volume":"54","author":"Y Gao","year":"2019","unstructured":"Gao, Y., Li, L., Li, T., Ma, L., Yuan, M., Sun, W., et al. (2019). Simvastatin delays castrationresistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin1. International Journal of Oncology, 54(6), 2054\u20132068. https:\/\/doi.org\/10.3892\/ijo.2019.4774.","journal-title":"International Journal of Oncology"},{"issue":"4 Pt 1","key":"9874_CR119","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.ju.0000030164.80605.b9","volume":"168","author":"V Mouraviev","year":"2002","unstructured":"Mouraviev, V., Li, L., Tahir, S. A., Yang, G., Timme, T. M., Goltsov, A., et al. (2002). The role of caveolin-1 in androgen insensitive prostate cancer. The Journal of Urology, 168(4 Pt 1), 1589\u20131596. https:\/\/doi.org\/10.1097\/01.ju.0000030164.80605.b9.","journal-title":"The Journal of Urology"},{"issue":"1","key":"9874_CR120","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.eururo.2013.08.011","volume":"66","author":"P Rajan","year":"2014","unstructured":"Rajan, P., Sudbery, I. M., Villasevil, M. E. M., Mui, E., Fleming, J., Davis, M., et al. (2014). Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. European Urology, 66(1), 32\u201339. https:\/\/doi.org\/10.1016\/j.eururo.2013.08.011.","journal-title":"European Urology"},{"issue":"9","key":"9874_CR121","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1158\/1541-7786.mcr-09-0071","volume":"7","author":"M Watanabe","year":"2009","unstructured":"Watanabe, M., Yang, G., Cao, G., Tahir, S. A., Naruishi, K., Tabata, K.-I., et al. (2009). Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression. Molecular Cancer Research, 7(9), 1446\u20131455. https:\/\/doi.org\/10.1158\/1541-7786.mcr-09-0071.","journal-title":"Molecular Cancer Research"},{"issue":"3","key":"9874_CR122","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1158\/0008-5472.CAN-07-2668","volume":"68","author":"SA Tahir","year":"2008","unstructured":"Tahir, S. A., Yang, G., Goltsov, A. A., Watanabe, M., Tabata, K., Addai, J., et al. (2008). Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer. Cancer Research, 68(3), 731\u2013739. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2668.","journal-title":"Cancer Research"},{"issue":"10","key":"9874_CR123","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1158\/0008-5472.can-05-1847","volume":"66","author":"GE Ayala","year":"2006","unstructured":"Ayala, G. E., Dai, H., Tahir, S. A., Li, R., Timme, T., Ittmann, M., et al. (2006). Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Research, 66(10), 5159\u20135164. https:\/\/doi.org\/10.1158\/0008-5472.can-05-1847.","journal-title":"Cancer Research"},{"issue":"23","key":"9874_CR124","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.4161\/cbt.8.23.10138","volume":"8","author":"SA Tahir","year":"2009","unstructured":"Tahir, S. A., Park, S., & Thompson, T. C. (2009). Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells. Cancer Biology & Therapy, 8(23), 2286.","journal-title":"Cancer Biology & Therapy"},{"issue":"29","key":"9874_CR125","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/sj.onc.1203654","volume":"19","author":"TL Timme","year":"2000","unstructured":"Timme, T. L., Goltsov, A., Tahir, S., Likun, L., Jianxiang, W., Chengzhen, R., et al. (2000). Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene, 19(29), 3256\u20133265.","journal-title":"Oncogene"},{"issue":"26","key":"9874_CR126","doi-asserted-by":"publisher","first-page":"25134","DOI":"10.1074\/jbc.M501186200","volume":"280","author":"TM Williams","year":"2005","unstructured":"Williams, T. M., Hassan, G. S., Li, J., Cohen, A. W., Medina, F., Frank, P. G., et al. (2005). Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer. The Journal of Biological Chemistry, 280(26), 25134.","journal-title":"The Journal of Biological Chemistry"},{"issue":"11","key":"9874_CR127","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/1541-7786.mcr-09-0255","volume":"7","author":"L Li","year":"2009","unstructured":"Li, L., Ren, C., Yang, G., Goltsov, A. A., Tabata, K.-I., & Thompson, T. C. (2009). Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells. Molecular Cancer Research, 7(11), 1781\u20131791. https:\/\/doi.org\/10.1158\/1541-7786.mcr-09-0255.","journal-title":"Molecular Cancer Research"},{"issue":"46","key":"9874_CR128","doi-asserted-by":"publisher","first-page":"33284","DOI":"10.1074\/jbc.M705089200","volume":"282","author":"X Zhang","year":"2007","unstructured":"Zhang, X., Ling, M. T., Wang, Q., Lau, C. K., Leung, S. C., Lee, T. K., et al. (2007). Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. The Journal of Biological Chemistry, 282(46), 33284\u201333294. https:\/\/doi.org\/10.1074\/jbc.M705089200.","journal-title":"The Journal of Biological Chemistry"},{"key":"9874_CR129","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/rru.S173377","volume":"10","author":"T Kamibeppu","year":"2018","unstructured":"Kamibeppu, T., Yamasaki, K., Nakahara, K., Nagai, T., Terada, N., Tsukino, H., et al. (2018). Caveolin-1 and -2 regulate cell motility in castration-resistant prostate cancer. Research and Reports in Urology, 10, 135\u2013144. https:\/\/doi.org\/10.2147\/rru.S173377.","journal-title":"Research and Reports in Urology"},{"issue":"7","key":"9874_CR130","doi-asserted-by":"publisher","first-page":"635","DOI":"10.18632\/oncoscience.180","volume":"2","author":"ZD Nassar","year":"2015","unstructured":"Nassar, Z. D., Hill, M. M., Parton, R. G., Francois, M., & Parat, M. O. (2015). Non-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesis. Oncoscience, 2(7), 635\u2013645.","journal-title":"Oncoscience"},{"issue":"3","key":"9874_CR131","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2337\/db10-0744","volume":"60","author":"N Aboulaich","year":"2011","unstructured":"Aboulaich, N., Chui, P. C., Asara, J. M., Flier, J. S., & Maratos-Flier, E. (2011). Polymerase I and transcript release factor regulates lipolysis via a phosphorylation-dependent mechanism. Diabetes, 60(3), 757\u2013765. https:\/\/doi.org\/10.2337\/db10-0744.","journal-title":"Diabetes"},{"issue":"1","key":"9874_CR132","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1091\/mbc.e03-06-0368","volume":"15","author":"A Pol","year":"2003","unstructured":"Pol, A., Martin, S., Fernandez, M. A., Ferguson, C., Carozzi, A., Luetterforst, R., et al. (2003). Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Molecular Biology of the Cell, 15(1), 99\u2013110. https:\/\/doi.org\/10.1091\/mbc.e03-06-0368.","journal-title":"Molecular Biology of the Cell"},{"issue":"3","key":"9874_CR133","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.bbrc.2006.09.094","volume":"350","author":"N Aboulaich","year":"2006","unstructured":"Aboulaich, N., \u00d6rtegren, U., Vener, A. V., & Str\u00e5lfors, P. (2006). Association and insulin regulated translocation of hormone-sensitive lipase with PTRF. Biochemical and Biophysical Research Communications, 350(3), 657\u2013661. https:\/\/doi.org\/10.1016\/j.bbrc.2006.09.094.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9874_CR134","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-511x-7-3","volume":"7","author":"H Cao","year":"2008","unstructured":"Cao, H., Alston, L., Ruschman, J., & Hegele, R. A. (2008). Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia. Lipids in Health and Disease, 7, 3. https:\/\/doi.org\/10.1186\/1476-511x-7-3.","journal-title":"Lipids in Health and Disease"},{"issue":"4","key":"9874_CR135","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1210\/jc.2007-1328","volume":"93","author":"CA Kim","year":"2008","unstructured":"Kim, C. A., Delepine, M., Boutet, E., El Mourabit, H., Le Lay, S., Meier, M., et al. (2008). Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. The Journal of Clinical Endocrinology and Metabolism, 93(4), 1129\u20131134. https:\/\/doi.org\/10.1210\/jc.2007-1328.","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"9","key":"9874_CR136","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1002\/ajmg.a.33578","volume":"152a","author":"S Shastry","year":"2010","unstructured":"Shastry, S., Delgado, M. R., Dirik, E., Turkmen, M., Agarwal, A. K., & Garg, A. (2010). Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. American Journal of Medical Genetics. Part A, 152a(9), 2245\u20132253. https:\/\/doi.org\/10.1002\/ajmg.a.33578.","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"9","key":"9874_CR137","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1172\/jci38660","volume":"119","author":"YK Hayashi","year":"2009","unstructured":"Hayashi, Y. K., Matsuda, C., Ogawa, M., Goto, K., Tominaga, K., Mitsuhashi, S., et al. (2009). Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. The Journal of Clinical Investigation, 119(9), 2623\u20132633. https:\/\/doi.org\/10.1172\/jci38660.","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"9874_CR138","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cmet.2012.01.004","volume":"15","author":"IW Asterholm","year":"2012","unstructured":"Asterholm, I. W., Mundy, D. I., Weng, J., Anderson, R. G., & Scherer, P. E. (2012). Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metabolism, 15(2), 171\u2013185. https:\/\/doi.org\/10.1016\/j.cmet.2012.01.004.","journal-title":"Cell Metabolism"},{"issue":"2","key":"9874_CR139","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.celrep.2013.06.017","volume":"4","author":"MA Fernandez-Rojo","year":"2013","unstructured":"Fernandez-Rojo, M. A., Gongora, M., Fitzsimmons, R. L., Martel, N., Martin, S. D., Nixon, S. J., et al. (2013). Caveolin-1 is necessary for hepatic oxidative lipid metabolism: evidence for crosstalk between caveolin-1 and bile acid signaling. Cell Reports, 4(2), 238\u2013247. https:\/\/doi.org\/10.1016\/j.celrep.2013.06.017.","journal-title":"Cell Reports"},{"issue":"11","key":"9874_CR140","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1096\/fj.12-215798","volume":"26","author":"HN Fridolfsson","year":"2012","unstructured":"Fridolfsson, H. N., Kawaraguchi, Y., Ali, S. S., Panneerselvam, M., Niesman, I. R., Finley, J. C., et al. (2012). Mitochondria-localized caveolin in adaptation to cellular stress and injury. The FASEB Journal, 26(11), 4637\u20134649. https:\/\/doi.org\/10.1096\/fj.12-215798.","journal-title":"The FASEB Journal"},{"issue":"3","key":"9874_CR141","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.pcan.4500879","volume":"9","author":"Y Liu","year":"2006","unstructured":"Liu, Y. (2006). Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer and Prostatic Diseases, 9(3), 230\u2013234. https:\/\/doi.org\/10.1038\/sj.pcan.4500879.","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"9874_CR142","doi-asserted-by":"publisher","unstructured":"Mah, C. Y., Nassar, Z. D., Swinnen, J. V., & Butler, L. M. (2019). Lipogenic effects of androgen signaling in normal and malignant prostate. Asian Journal of Urology. https:\/\/doi.org\/10.1016\/j.ajur.2019.12.003.","DOI":"10.1016\/j.ajur.2019.12.003"},{"issue":"10","key":"9874_CR143","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.bbalip.2013.03.010","volume":"1831","author":"G Zadra","year":"2013","unstructured":"Zadra, G., Photopoulos, C., & Loda, M. (2013). The fat side of prostate cancer. Biochimica et Biophysica Acta, 1831(10), 1518\u20131532. https:\/\/doi.org\/10.1016\/j.bbalip.2013.03.010.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"10","key":"9874_CR144","first-page":"707","volume":"1","author":"S Rossi","year":"2003","unstructured":"Rossi, S., Graner, E., Febbo, P., Weinstein, L., Bhattacharya, N., Onody, T., et al. (2003). Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Molecular Cancer Research, 1(10), 707\u2013715.","journal-title":"Molecular Cancer Research"},{"issue":"2","key":"9874_CR145","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/1097-0215(20001015)88:2<176::aid-ijc5>3.0.co;2-3","volume":"88","author":"JV Swinnen","year":"2000","unstructured":"Swinnen, J. V., Vanderhoydonc, F., Elgamal, A. A., Eelen, M., Vercaeren, I., Joniau, S., et al. (2000). Selective activation of the fatty acid synthesis pathway in human prostate cancer. International Journal of Cancer, 88(2), 176\u2013179. https:\/\/doi.org\/10.1002\/1097-0215(20001015)88:2<176::aid-ijc5>3.0.co;2-3.","journal-title":"International Journal of Cancer"},{"issue":"9","key":"9874_CR146","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/s0046-8177(96)90218-x","volume":"27","author":"MS Shurbaji","year":"1996","unstructured":"Shurbaji, M. S., Kalbfleisch, J. H., & Thurmond, T. S. (1996). Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Human Pathology, 27(9), 917\u2013921. https:\/\/doi.org\/10.1016\/s0046-8177(96)90218-x.","journal-title":"Human Pathology"},{"issue":"5","key":"9874_CR147","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.ajpath.2011.01.038","volume":"178","author":"E Boopathi","year":"2011","unstructured":"Boopathi, E., Gomes, C. M., Goldfarb, R., John, M., Srinivasan, V. G., Alanzi, J., et al. (2011). Transcriptional repression of caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings. The American Journal of Pathology, 178(5), 2236\u20132251. https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.038.","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"9874_CR148","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1074\/jbc.M407941200","volume":"280","author":"S Cao","year":"2005","unstructured":"Cao, S., Fernandez-Zapico, M. E., Jin, D., Puri, V., Cook, T. A., Lerman, L. O., et al. (2005). KLF11-mediated repression antagonizes Sp1\/sterol-responsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. The Journal of Biological Chemistry, 280(3), 1901\u20131910. https:\/\/doi.org\/10.1074\/jbc.M407941200.","journal-title":"The Journal of Biological Chemistry"},{"issue":"20","key":"9874_CR149","doi-asserted-by":"publisher","first-page":"10693","DOI":"10.1073\/pnas.94.20.10693","volume":"94","author":"A Bist","year":"1997","unstructured":"Bist, A., Fielding, P. E., & Fielding, C. J. (1997). Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proceedings of the National Academy of Sciences of the United States of America, 94(20), 10693\u201310698. https:\/\/doi.org\/10.1073\/pnas.94.20.10693.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"14","key":"9874_CR150","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.4161\/cc.7.14.6475","volume":"7","author":"D Di Vizio","year":"2008","unstructured":"Di Vizio, D., Adam, R. M., Kim, J., Kim, R., Sotgia, F., Williams, T., et al. (2008). Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. Cell Cycle, 7(14), 2257\u20132267. https:\/\/doi.org\/10.4161\/cc.7.14.6475.","journal-title":"Cell Cycle"},{"issue":"8","key":"9874_CR151","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.4161\/cbt.6.8.4447","volume":"6","author":"D Di Vizio","year":"2007","unstructured":"Di Vizio, D., Sotgia, F., Williams, T. M., Hassan, G. S., Capozza, F., Frank, P. G., et al. (2007). Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression. Cancer Biology & Therapy, 6(8), 1269\u20131274.","journal-title":"Cancer Biology & Therapy"},{"issue":"29","key":"9874_CR152","doi-asserted-by":"publisher","first-page":"46321","DOI":"10.18632\/oncotarget.10113","volume":"7","author":"T Karantanos","year":"2016","unstructured":"Karantanos, T., Karanika, S., Wang, J., Yang, G., Dobashi, M., Park, S., et al. (2016). Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer. Oncotarget, 7(29), 46321\u201346334. https:\/\/doi.org\/10.18632\/oncotarget.10113.","journal-title":"Oncotarget"},{"key":"9874_CR153","doi-asserted-by":"publisher","unstructured":"Watt, M. J., Clark, A. K., Selth, L. A., Haynes, V. R., Lister, N., Rebello, R., et al. (2019). Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Science Translational Medicine, 11(478). https:\/\/doi.org\/10.1126\/scitranslmed.aau5758.","DOI":"10.1126\/scitranslmed.aau5758"},{"issue":"1","key":"9874_CR154","first-page":"1","volume":"1","author":"HM Mattern","year":"2009","unstructured":"Mattern, H. M., Raikar, L. S., & Hardin, C. D. (2009). The effect of caveolin-1 (Cav-1) on fatty acid uptake and CD36 localization and lipotoxicity in vascular smooth muscle (VSM) cells. International Journal of Physiology, Pathophysiology and Pharmacology, 1(1), 1\u201314.","journal-title":"International Journal of Physiology, Pathophysiology and Pharmacology"},{"issue":"4","key":"9874_CR155","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbalip.2006.03.016","volume":"1761","author":"A Ring","year":"2006","unstructured":"Ring, A., Le Lay, S., Pohl, J., Verkade, P., & Stremmel, W. (2006). Caveolin-1 is required for fatty acid translocase (FAT\/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts. Biochimica et Biophysica Acta, 1761(4), 416\u2013423. https:\/\/doi.org\/10.1016\/j.bbalip.2006.03.016.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"9874_CR156","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1021\/bi051999b","volume":"45","author":"T Meshulam","year":"2006","unstructured":"Meshulam, T., Simard, J. R., Wharton, J., Hamilton, J. A., & Pilch, P. F. (2006). Role of caveolin-1 and cholesterol in transmembrane fatty acid movement. Biochemistry, 45(9), 2882\u20132893. https:\/\/doi.org\/10.1021\/bi051999b.","journal-title":"Biochemistry"},{"issue":"5","key":"9874_CR157","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1194\/jlr.M900251","volume":"51","author":"JR Simard","year":"2010","unstructured":"Simard, J. R., Meshulam, T., Pillai, B. K., Kirber, M. T., Brunaldi, K., Xu, S., et al. (2010). Caveolins sequester FA on the cytoplasmic leaflet of the plasma membrane, augment triglyceride formation, and protect cells from lipotoxicity. Journal of Lipid Research, 51(5), 914\u2013922. https:\/\/doi.org\/10.1194\/jlr.M900251.","journal-title":"Journal of Lipid Research"},{"issue":"12","key":"9874_CR158","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.1074\/jbc.M113.546242","volume":"289","author":"S-Y Ding","year":"2014","unstructured":"Ding, S.-Y., Lee, M.-J., Summer, R., Liu, L., Fried, S. K., & Pilch, P. F. (2014). Pleiotropic effects of cavin-1 deficiency on lipid metabolism. The Journal of Biological Chemistry, 289(12), 8473\u20138483. https:\/\/doi.org\/10.1074\/jbc.M113.546242.","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"9874_CR159","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1158\/0008-5472.CAN-12-3040","volume":"73","author":"SA Tahir","year":"2013","unstructured":"Tahir, S. A., Yang, G., Goltsov, A., Song, K.-D., Ren, C., Wang, J., et al. (2013). Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer. Cancer Research, 73(6), 1900\u20131911. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3040.","journal-title":"Cancer Research"},{"issue":"2","key":"9874_CR160","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/path.2809","volume":"223","author":"R Flavin","year":"2011","unstructured":"Flavin, R., Zadra, G., & Loda, M. (2011). Metabolic alterations and targeted therapies in prostate cancer. The Journal of Pathology, 223(2), 283\u2013294. https:\/\/doi.org\/10.1002\/path.2809.","journal-title":"The Journal of Pathology"},{"issue":"5930","key":"9874_CR161","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324(5930), 1029\u20131033. https:\/\/doi.org\/10.1126\/science.1160809.","journal-title":"Science"},{"issue":"10","key":"9874_CR162","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1093\/emboj\/17.10.2855","volume":"17","author":"P Jansa","year":"1998","unstructured":"Jansa, P., Mason, S. W., Hoffmann-Rohrer, U., & Grummt, I. (1998). Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes. The EMBO Journal, 17(10), 2855\u20132864. https:\/\/doi.org\/10.1093\/emboj\/17.10.2855.","journal-title":"The EMBO Journal"},{"issue":"2","key":"9874_CR163","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/nar\/29.2.423","volume":"29","author":"P Jansa","year":"2001","unstructured":"Jansa, P., Burek, C., Sander, E. E., & Grummt, I. (2001). The transcript release factor PTRF augments ribosomal gene transcription by facilitating reinitiation of RNA polymerase I. Nucleic Acids Research, 29(2), 423\u2013429.","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"9874_CR164","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s004380051112","volume":"262","author":"P Jansa","year":"1999","unstructured":"Jansa, P., & Grummt, I. (1999). Mechanism of transcription termination: PTRF interacts with the largest subunit of RNA polymerase I and dissociates paused transcription complexes from yeast and mouse. Molecular and General Genetics MGG, 262(3), 508\u2013514.","journal-title":"Molecular and General Genetics MGG"},{"issue":"1","key":"9874_CR165","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbamem.2005.09.013","volume":"1717","author":"J Vinten","year":"2005","unstructured":"Vinten, J., Johnsen, A., Roepstorff, P., Harp\u00f8th, J., & Tranum-Jensen, J. (2005). Identification of a major protein on the cytosolic face of caveolae. Biochimica et Biophysica Acta, Biomembranes, 1717(1), 34\u201340.","journal-title":"Biochimica et Biophysica Acta, Biomembranes"},{"issue":"7","key":"9874_CR166","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1074\/jbc.M707890200","volume":"283","author":"L Liu","year":"2008","unstructured":"Liu, L., & Pilch, P. F. (2008). A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. The Journal of Biological Chemistry, 283(7), 4314\u20134322.","journal-title":"The Journal of Biological Chemistry"},{"key":"9874_CR167","doi-asserted-by":"publisher","unstructured":"Liu, L., & Pilch, P. F. (2016). PTRF\/Cavin-1 promotes efficient ribosomal RNA transcription in response to metabolic challenges. Elife, 5. https:\/\/doi.org\/10.7554\/eLife.17508.","DOI":"10.7554\/eLife.17508"},{"issue":"1","key":"9874_CR168","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/s41467-019-11111-1","volume":"10","author":"K-A McMahon","year":"2019","unstructured":"McMahon, K.-A., Wu, Y., Gambin, Y., Sierecki, E., Tillu, V. A., Hall, T., et al. (2019). Identification of intracellular cavin target proteins reveals cavin-PP1alpha interactions regulate apoptosis. Nature Communications, 10(1), 3279. https:\/\/doi.org\/10.1038\/s41467-019-11111-1.","journal-title":"Nature Communications"},{"issue":"3","key":"9874_CR169","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.cell.2010.12.031","volume":"144","author":"B Sinha","year":"2011","unstructured":"Sinha, B., Koster, D., Ruez, R., Gonnord, P., Bastiani, M., Abankwa, D., et al. (2011). Cells respond to mechanical stress by rapid disassembly of caveolae. Cell, 144(3), 402\u2013413. https:\/\/doi.org\/10.1016\/j.cell.2010.12.031.","journal-title":"Cell"},{"key":"9874_CR170","doi-asserted-by":"publisher","first-page":"e01434","DOI":"10.7554\/eLife.01434","volume":"3","author":"Y Gambin","year":"2013","unstructured":"Gambin, Y., Ariotti, N., McMahon, K. A., Bastiani, M., Sierecki, E., Kovtun, O., et al. (2013). Single-molecule analysis reveals self assembly and nanoscale segregation of two distinct cavin subcomplexes on caveolae. Elife, 3, e01434. https:\/\/doi.org\/10.7554\/eLife.01434.","journal-title":"Elife"},{"issue":"2-3","key":"9874_CR171","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejcb.2010.06.004","volume":"90","author":"CS Aung","year":"2011","unstructured":"Aung, C. S., Hill, M. M., Bastiani, M., Parton, R. G., & Parat, M. O. (2011). PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9. European Journal of Cell Biology, 90(2-3), 136\u2013142. https:\/\/doi.org\/10.1016\/j.ejcb.2010.06.004.","journal-title":"European Journal of Cell Biology"},{"issue":"8","key":"9874_CR172","doi-asserted-by":"publisher","first-page":"e43041","DOI":"10.1371\/journal.pone.0043041","volume":"7","author":"MM Hill","year":"2012","unstructured":"Hill, M. M., Daud, N. H., Aung, C. S., Loo, D., Martin, S., Murphy, S., et al. (2012). Co-regulation of cell polarization and migration by caveolar proteins PTRF\/Cavin-1 and caveolin-1. PLoS One, 7(8), e43041. https:\/\/doi.org\/10.1371\/journal.pone.0043041.","journal-title":"PLoS One"},{"issue":"2","key":"9874_CR173","doi-asserted-by":"publisher","first-page":"M111.012245","DOI":"10.1074\/mcp.M111.012245","volume":"11","author":"KL Inder","year":"2012","unstructured":"Inder, K. L., Zheng, Y. Z., Davis, M. J., Moon, H., Loo, D., Nguyen, H., et al. (2012). Expression of PTRF in PC-3 cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways. Molecular & Cellular Proteomics, 11(2), M111.012245. https:\/\/doi.org\/10.1074\/mcp.M111.012245.","journal-title":"Molecular & Cellular Proteomics"},{"key":"9874_CR174","doi-asserted-by":"publisher","unstructured":"Inder, K. L., Ruelcke, J. E., Petelin, L., Moon, H., Choi, E., Rae, J., et al. (2014). Cavin-1\/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation. Journal of Extracellular Vesicles, 3. https:\/\/doi.org\/10.3402\/jev.v3.23784.","DOI":"10.3402\/jev.v3.23784"},{"key":"9874_CR175","doi-asserted-by":"publisher","unstructured":"Ni, Y., Hao, J., Hou, X., Du, W., Yu, Y., Chen, T., et al. (2018). Dephosphorylated polymerase I and transcript release factor prevents allergic asthma exacerbations by limiting IL-33 release.\u00a0\u00a0Frontiers in Immunology, 9(1422). https:\/\/doi.org\/10.3389\/fimmu.2018.01422.","DOI":"10.3389\/fimmu.2018.01422"},{"issue":"7","key":"9874_CR176","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/cr.2011.56","volume":"21","author":"L Bai","year":"2011","unstructured":"Bai, L., Deng, X., Li, J., Wang, M., Li, Q., An, W., et al. (2011). Regulation of cellular senescence by the essential caveolar component PTRF\/Cavin-1. Cell Research, 21(7), 1088\u20131101. https:\/\/doi.org\/10.1038\/cr.2011.56.","journal-title":"Cell Research"},{"issue":"Pt 2","key":"9874_CR177","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1042\/bj20040647","volume":"383","author":"N Aboulaich","year":"2004","unstructured":"Aboulaich, N., Vainonen, J. P., Stralfors, P., & Vener, A. V. (2004). Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes. The Biochemical Journal, 383(Pt 2), 237\u2013248. https:\/\/doi.org\/10.1042\/bj20040647.","journal-title":"The Biochemical Journal"},{"issue":"3","key":"9874_CR178","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.bbrc.2014.12.035","volume":"456","author":"Z Wei","year":"2015","unstructured":"Wei, Z., Zou, X., Wang, H., Lei, J., Wu, Y., & Liao, K. (2015). The N-terminal leucine-zipper motif in PTRF\/cavin-1 is essential and sufficient for its caveolae-association. Biochemical and Biophysical Research Communications, 456(3), 750\u2013756. https:\/\/doi.org\/10.1016\/j.bbrc.2014.12.035.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"22","key":"9874_CR179","doi-asserted-by":"publisher","first-page":"10339","DOI":"10.1073\/pnas.92.22.10339","volume":"92","author":"M Murata","year":"1995","unstructured":"Murata, M., Peranen, J., Schreiner, R., Wieland, F., Kurzchalia, T. V., & Simons, K. (1995). VIP21\/caveolin is a cholesterol-binding protein. Proceedings of the National Academy of Sciences of the United States of America, 92(22), 10339\u201310343. https:\/\/doi.org\/10.1073\/pnas.92.22.10339.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9874_CR180","doi-asserted-by":"crossref","unstructured":"Hailstones, D., Sleer, L. S., Parton, R. G., & Stanley, K. K. (1998). Regulation of caveolin and caveolae by cholesterol in MDCK cells.\u00a0Journal of Lipid Research, 39(2), 369\u2013379.","DOI":"10.1016\/S0022-2275(20)33898-0"},{"key":"9874_CR181","doi-asserted-by":"publisher","unstructured":"Rothberg, K. G., Ying, Y. S., Kamen, B. A., & Anderson, R. G. W. (1990). Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate.\u00a0Journal of Cell Biology, 111(6 II), 2931\u20132938. https:\/\/doi.org\/10.1083\/jcb.111.6.2931.","DOI":"10.1083\/jcb.111.6.2931"},{"issue":"4","key":"9874_CR182","doi-asserted-by":"publisher","first-page":"e34516","DOI":"10.1371\/journal.pone.0034516","volume":"7","author":"MR Breen","year":"2012","unstructured":"Breen, M. R., Camps, M., Carvalho-Simoes, F., Zorzano, A., & Pilch, P. F. (2012). Cholesterol depletion in adipocytes causes caveolae collapse concomitant with proteosomal degradation of cavin-2 in a switch-like fashion. PLoS One, 7(4), e34516. https:\/\/doi.org\/10.1371\/journal.pone.0034516.","journal-title":"PLoS One"},{"issue":"1","key":"9874_CR183","doi-asserted-by":"publisher","first-page":"111","DOI":"10.18388\/abp.2017_2305","volume":"65","author":"K Kowalska","year":"2018","unstructured":"Kowalska, K., Habrowska-Gorczynska, D. E., Neumayer, C., Bolliger, M., Domenig, C., Piastowska-Ciesielska, A. W., et al. (2018). Lower levels of Caveolin-1 and higher levels of endothelial nitric oxide synthase are observed in abdominal aortic aneurysm patients treated with simvastatin. Acta Biochimica Polonica, 65(1), 111\u2013118. https:\/\/doi.org\/10.18388\/abp.2017_2305.","journal-title":"Acta Biochimica Polonica"},{"issue":"10","key":"9874_CR184","doi-asserted-by":"publisher","first-page":"7438","DOI":"10.18632\/oncotarget.3476","volume":"6","author":"H Moon","year":"2015","unstructured":"Moon, H., Ruelcke, J. E., Choi, E., Sharpe, L. J., Nassar, Z. D., Bielefeldt-Ohmann, H., et al. (2015). Diet-induced hypercholesterolemia promotes androgen-independent prostate cancer metastasis via IQGAP1 and caveolin-1. Oncotarget, 6(10), 7438\u20137453. https:\/\/doi.org\/10.18632\/oncotarget.3476.","journal-title":"Oncotarget"},{"issue":"4","key":"9874_CR185","doi-asserted-by":"publisher","first-page":"739","DOI":"10.5114\/aoms.2012.30955","volume":"9","author":"AW Piastowska-Ciesielska","year":"2013","unstructured":"Piastowska-Ciesielska, A. W., Koz\u0142owski, M., Wagner, W., Domi\u0144ska, K., & Och\u0119dalski, T. (2013). Effect of an angiotensin II type 1 receptor blocker on caveolin-1 expression in prostate cancer cells. Archives of Medical Science. AMS, 9(4), 739\u2013744. https:\/\/doi.org\/10.5114\/aoms.2012.30955.","journal-title":"Archives of Medical Science. AMS"},{"issue":"4b","key":"9874_CR186","first-page":"2977","volume":"26","author":"K Iguchi","year":"2006","unstructured":"Iguchi, K., Matsunaga, S., Nakano, T., Usui, S., & Hirano, K. (2006). Inhibition of caveolin-1 expression by incadronate in PC-3 prostate cells. Anticancer Research, 26(4b), 2977\u20132981.","journal-title":"Anticancer Research"},{"issue":"4","key":"9874_CR187","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.neo.7900165","volume":"3","author":"M Goh","year":"2001","unstructured":"Goh, M., Chen, F., Paulsen, M. T., Yeager, A. M., Dyer, E. S., & Ljungman, M. (2001). Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells. Neoplasia, 3(4), 331\u2013338. https:\/\/doi.org\/10.1038\/sj.neo.7900165.","journal-title":"Neoplasia"},{"issue":"1-2","key":"9874_CR188","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11010-015-2429-8","volume":"406","author":"Z Guo","year":"2015","unstructured":"Guo, Z., Hu, X., Xing, Z., Xing, R., Lv, R., Cheng, X., et al. (2015). Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1\/AKT\/mTOR pathway. Molecular and Cellular Biochemistry, 406(1-2), 111\u2013119. https:\/\/doi.org\/10.1007\/s11010-015-2429-8.","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"8","key":"9874_CR189","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/pros.22960","volume":"75","author":"GE Hirsch","year":"2015","unstructured":"Hirsch, G. E., Parisi, M. M., Martins, L. A., Andrade, C. M., Barbe-Tuana, F. M., & Guma, F. T. (2015). gamma-Oryzanol reduces caveolin-1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines. Prostate, 75(8), 783\u2013797. https:\/\/doi.org\/10.1002\/pros.22960.","journal-title":"Prostate"},{"key":"9874_CR190","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.biopha.2016.10.104","volume":"84","author":"S Yuan","year":"2016","unstructured":"Yuan, S., Wang, L., Chen, X., Fan, B., Yuan, Q., Zhang, H., et al. (2016). Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1\/CD147\/MMPs pathway. Biomedicine & Pharmacotherapy, 84, 1776\u20131782. https:\/\/doi.org\/10.1016\/j.biopha.2016.10.104.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"11","key":"9874_CR191","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/carcin\/bgn018","volume":"29","author":"P Palozza","year":"2008","unstructured":"Palozza, P., Sestito, R., Picci, N., Lanza, P., Monego, G., & Ranelletti, F. O. (2008). The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells. Carcinogenesis, 29(11), 2153\u20132161. https:\/\/doi.org\/10.1093\/carcin\/bgn018.","journal-title":"Carcinogenesis"},{"issue":"11","key":"9874_CR192","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40265-019-01161-6","volume":"79","author":"A Markham","year":"2019","unstructured":"Markham, A. (2019). Alpelisib: first global approval. Drugs, 79(11), 1249\u20131253. https:\/\/doi.org\/10.1007\/s40265-019-01161-6.","journal-title":"Drugs"},{"issue":"5","key":"9874_CR193","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.cd-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2(5), 401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.cd-12-0095.","journal-title":"Cancer Discovery"},{"issue":"269","key":"9874_CR194","doi-asserted-by":"publisher","first-page":"l1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science Signaling, 6(269), l1. https:\/\/doi.org\/10.1126\/scisignal.2004088.","journal-title":"Science Signaling"},{"issue":"8","key":"9874_CR195","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/nbt.1914","volume":"29","author":"JR Prensner","year":"2011","unstructured":"Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., et al. (2011). Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nature Biotechnology, 29(8), 742\u2013749. https:\/\/doi.org\/10.1038\/nbt.1914.","journal-title":"Nature Biotechnology"},{"issue":"9","key":"9874_CR196","first-page":"3430","volume":"6","author":"G Yang","year":"2000","unstructured":"Yang, G., Addai, J., Ittmann, M., Wheeler, T. M., & Thompson, T. C. (2000). Elevated caveolin-1 levels in African-American versus white-American prostate cancer. Clinical Cancer Research, 6(9), 3430\u20133433.","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"9874_CR197","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3892\/or.2011.1587","volume":"27","author":"J Gumulec","year":"2012","unstructured":"Gumulec, J., Sochor, J., Hlavna, M., Sztalmachova, M., Krizkova, S., Babula, P., et al. (2012). Caveolin-1 as a potential high-risk prostate cancer biomarker. Oncology Reports, 27(3), 831\u2013841. https:\/\/doi.org\/10.3892\/or.2011.1587.","journal-title":"Oncology Reports"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-020-09874-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T13:22:20Z","timestamp":1620048140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-020-09874-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":197,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["9874"],"URL":"https:\/\/doi.org\/10.1007\/s10555-020-09874-x","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"1 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}